Results for tag: "Verteporfin"

Verteporfin is a drug used to treat optical disorders, such as age-related macular degeneration (AMD) and pathologic myopia. It is a photosensitizer that is activated by light, and works by blocking the growth of new blood vessels in the eye. Verteporfin is administered intravenously and is used in combination with a laser to treat the affected area. It is the only drug approved by the FDA for the treatment of AMD. Verteporfin is a relatively new drug, and is still in the early stages of development. It is being studied for its potential to treat other optical disorders, such as diabetic retinopathy and retinal vein occlusion. The Verteporfin market is growing, as more people are being diagnosed with optical disorders. The drug is becoming increasingly popular due to its effectiveness and safety profile. Some companies in the Verteporfin market include Novartis, Pfizer, and Allergan. Show Less Read more